The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease
Gavin Jones, MD, and colleagues explore the landscape of radiation therapy in diffuse large B-cell lymphoma.
Controversies in Early-Stage Hodgkin’s Disease
Early-stage Hodgkin’s disease accounts for approximately 60% of all cases of the illness. Because of its excellent cure rate (80% to 90%) and high salvage rate, it is difficult to demonstrate survival advantages for